Literature DB >> 15247155

Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.

Johanna M Zuetenhorst1, Catharina M Korse, Johannes M G Bonfrer, Ellen Peter, Cornelis B H W Lamers, Babs G Taal.   

Abstract

BACKGROUND: Vasoactive peptides produced by neuroendocrine tumors can induce characteristic symptoms of the carcinoid syndrome (flushing, diarrhea, and wheezing). To what extent external factors provoke these symptoms and how excretion of 5-hydroxyindoleacetic acid (5-HIAA), the degradation product of serotonin, varies throughout the day remain unknown. In this study, we investigated whether symptoms and daily activity are related to 5-HIAA excretion and whether 24-h urine collection is needed.
METHODS: In 26 patients with metastatic carcinoid (14 men and 12 women; median age, 60 years) urine was collected in portions of 4 or 8 h during 2 days. Patients were asked to keep a diary in which they noted symptoms of flushes, consistency of stools, activities, and food intake.
RESULTS: Excretion of 5-HIAA in 24-h urine was increased in 88% of the patients (median, 515 micromol/24 h). Overnight-collected urine appeared the most representative for 24-h collection concentrations (correlation coefficient = 0.81). We found no clear correlation between symptoms of the carcinoid syndrome and degree of activity. Watery diarrhea was reported only by patients with strong variations in 5-HIAA excretion. One-half of the patients (n = 16) exhibited a high variability in urinary 5-HIAA excretion throughout the day, with increased concentrations most prominent in morning collections (P = 0.0074) and lower concentrations in the evening (P = 0.0034). In the other patients these curves were flat.
CONCLUSIONS: Cyclic changes in patients relate to high variability in 5-HIAA excretion. Overnight-collected urine can replace the 24-h urine collection, and marked variations in 5-HIAA excretion seem to be associated with severity of diarrhea.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247155     DOI: 10.1373/clinchem.2004.032151

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Long-term follow up of patients affected by pulmonary carcinoid at the Istituto Nazionale Tumori of Milan: a retrospective analysis.

Authors:  S Pusceddu; L Catena; M Valente; R Buzzoni; B Formisano; M Del Vecchio; M Ducceschi; L Tavecchio; A Fabbri; E Bajetta
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

Review 2.  The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity.

Authors:  Katerina Nikolovska; Ursula E Seidler; Christian Stock
Journal:  Front Physiol       Date:  2022-05-18       Impact factor: 4.755

3.  Transcriptional regulation of the human Na+/H+ exchanger NHE3 by serotonin in intestinal epithelial cells.

Authors:  Md Ruhul Amin; Leda Ghannad; Ahmad Othman; Ravinder K Gill; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Biochem Biophys Res Commun       Date:  2009-03-20       Impact factor: 3.575

4.  Measurement of urinary 5-HIAA: correlation between spot versus 24-h urine collection.

Authors:  Matilde Calanchini; Michael Tadman; Jesper Krogh; Andrea Fabbri; Ashley Grossman; Brian Shine
Journal:  Endocr Connect       Date:  2019-08-01       Impact factor: 3.335

Review 5.  Pediatric gastroenteropancreatic neuroendocrine tumor: A case report and review of the literature.

Authors:  Federica Gaiani; Nicola de'Angelis; Roberta Minelli; Stefano Kayali; Maria Clotilde Carra; Gian Luigi de'Angelis
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

6.  Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms.

Authors:  Anna Becker; Camilla Schalin-Jäntti; Outi Itkonen
Journal:  J Endocr Soc       Date:  2021-06-08

7.  Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors.

Authors:  Merete Gedde-Dahl; Espen Thiis-Evensen; Andreas Myklebust Tjølsen; Kjerstin Skrede Mordal; Morten Vatn; Deidi S Bergestuen
Journal:  Endocr Connect       Date:  2013-01-25       Impact factor: 3.335

8.  Blood transcript analysis and metastatic recurrent small bowel carcinoid management.

Authors:  Irvin M Modlin; Ignat Drozdov; Lisa Bodei; Mark Kidd
Journal:  BMC Cancer       Date:  2014-08-05       Impact factor: 4.430

Review 9.  Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations.

Authors:  Jean-Benoît Corcuff; Laurence Chardon; Ines El Hajji Ridah; Julie Brossaud
Journal:  Endocr Connect       Date:  2017-05-31       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.